as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹15.51
Change
+0.11 (0.71%)
Open
₹15.71
Prev. Close
₹15.4
Day High
₹15.71
Day Low
₹15.11
Volume Analysis
Traded
144,138
Delivered
101,112
Delivery %
70.15%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (3)
- •Promoter holding is falling
- •Below-average fundamentals quality score (39/100)
- •Low operating margin (-2.1%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹16.37 | ₹16.04 | ₹15.77 | ₹15.44 | ₹15.17 | ₹14.84 | ₹14.57 |
| Fibonacci | ₹16.04 | ₹15.81 | ₹15.67 | ₹15.44 | ₹15.21 | ₹15.07 | ₹14.84 |
| Camarilla | ₹15.68 | ₹15.62 | ₹15.57 | ₹15.44 | ₹15.46 | ₹15.4 | ₹15.35 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-61.55%
1 Week
-5.83%
1 Month
-3.9%
3 Months
-38.67%
6 Months
-61.62%
1 Year
+48.71%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹5.87
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
26.6%
Net margin 15.29% × asset turnover 1.5x × equity multiplier 1.16x
Company Overview
Sector
Healthcare
Market Cap
₹229 Cr
P/E (TTM)
38.9
ROE
16.5%
Book Value
₹2.1
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Take Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 39/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; below-average fundamentals quality score (39/100).
TopFund Score — Fundamentals Quality
39/100 — WeakData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is almost debt free.
- −Stock is trading at 7.40 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −The company has delivered a poor sales growth of -41.2% over past five years.
- −Tax rate seems low
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Trading window closed from October 1, 2026 until 48 hours after Q2 and half-year results.
September 22, 2026 cut-off date fixed for 25th AGM e-voting; AGM on September 29, 2026.
Submission of Newspaper Publication regarding dispatch of Notice of Annual General Meeting.
TAKE Limited submitted FY2025-26 annual report and AGM notice for September 29, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 30 |
| Expenses + | 6 | 2 | 2 | 16 | 2 | 1 | 3 | 1 | 0 | 0 | 0 | 55 | 31 |
| Operating Profit | -2 | -1 | -2 | -16 | -2 | -1 | -3 | -1 | 0 | 0 | 0 | -1 | 0 |
| OPM % | -54.93% | -2,900.0% | — | — | — | — | — | — | — | — | — | -1.51% | -0.89% |
| Other Income + | -2 | 0 | 4 | -94 | -1 | 0 | 51 | -3 | 0 | 7 | 1 | 5 | 1 |
| Interest | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -5 | -2 | 1 | -110 | -4 | -2 | 48 | -5 | -1 | 6 | 1 | 4 | 1 |
| Tax % | 3.5% | -18.42% | 248.61% | 0.55% | 1.63% | -3.66% | 0.0% | 0.0% | 0.0% | 2.48% | 0.0% | 0.0% | 0.0% |
| Net Profit + | -5 | -2 | -2 | -111 | -4 | -2 | 48 | -5 | -1 | 6 | 1 | 4 | 1 |
| EPS in Rs | 0 | 0 | 0 | -7 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 730 | 1,030 | 1,345 | 1,587 | 2,039 | 2,213 | 774 | 655 | 189 | 4 | 0 | 54 | 85 |
| Expenses + | 581 | 817 | 1,082 | 1,281 | 1,655 | 2,044 | 847 | 648 | 208 | 24 | 7 | 56 | 86 |
| Operating Profit | 149 | 213 | 262 | 307 | 384 | 169 | -73 | 7 | -19 | -20 | -7 | -2 | -2 |
| OPM % | 20.0% | 21.0% | 20.0% | 19.0% | 19.0% | 8.0% | -9.0% | 1.1% | -10.0% | -569.0% | — | -3.5% | -2.1% |
| Other Income + | 8 | 21 | 13 | 6 | 11 | 26 | -211 | -677 | -56 | -92 | 47 | 13 | 15 |
| Interest | 13 | 15 | 23 | 21 | 25 | 41 | 37 | 29 | 7 | 2 | 2 | 0 | 0 |
| Depreciation | 60 | 74 | 87 | 104 | 154 | 167 | 115 | 80 | 17 | 1 | 0 | 0 | 0 |
| Profit before tax | 85 | 145 | 165 | 188 | 216 | -13 | -437 | -779 | -99 | -116 | 37 | 11 | 13 |
| Tax % | 6.0% | 14.0% | 11.0% | 15.0% | 17.0% | -15.0% | 3.0% | 0.0% | 2.0% | 3.0% | 0.0% | 1.0% | — |
| Net Profit + | 80 | 125 | 146 | 160 | 178 | -11 | -450 | -782 | -100 | -120 | 37 | 11 | 13 |
| EPS in Rs | 6 | 10 | 11 | 11 | 12 | -1 | -31 | -53 | -7 | -8 | 3 | 1 | 1 |
| Dividend Payout % | 17.0% | 10.0% | 9.0% | 15.0% | 8.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 512 | 619 | 898 | 1,314 | 1,504 | 1,561 | 1,110 | 166 | 94 | -24 | 6 | 16 |
| Borrowings + | 209 | 336 | 237 | 323 | 474 | 553 | 514 | 59 | 46 | 37 | 0 | 0 |
| Other Liabilities + | 189 | 246 | 221 | 189 | 339 | 336 | 187 | 984 | 69 | 60 | 16 | 5 |
| Total Liabilities | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,465 | 1,826 | 1,223 | 224 | 88 | 36 | 36 |
| Fixed Assets + | 359 | 543 | 554 | 589 | 1,091 | 1,234 | 934 | 101 | 73 | 30 | 0 | 0 |
| CWIP | 17 | 3 | 21 | 42 | 41 | 1 | 0 | 3 | 11 | 0 | 0 | 0 |
| Investments | 6 | 21 | 10 | 59 | 10 | 18 | 7 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 541 | 647 | 785 | 1,150 | 1,188 | 1,213 | 885 | 1,119 | 140 | 58 | 36 | 36 |
| Total Assets | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,465 | 1,826 | 1,223 | 224 | 88 | 36 | 36 |
| Equity Capital | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 74 | 151 | 56 | 121 | 104 | 211 | 135 | 30 | 20 | 9 | -16 | -4 |
| Cash from Investing Activity + | -14 | -292 | -130 | -179 | -474 | -233 | -57 | 15 | -3 | -7 | 22 | 2 |
| Cash from Financing Activity + | -11 | 111 | 56 | 302 | 100 | 21 | -84 | -55 | -36 | -12 | -3 | -1 |
| Net Cash Flow | 49 | -30 | -18 | 243 | -270 | -2 | -6 | -10 | -18 | -10 | 3 | -3 |
| CFO/OP | 52 | 76 | 26 | 44 | 30 | 156 | -212 | 704 | -114 | -43 | 217 | 208 |
| Free Cash Flow | 46 | 35 | -30 | 39 | -23 | 54 | 133 | -2 | -12 | 2 | -16 | -4 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 46.57% | 46.59% | 46.56% | 46.58% | 46.58% | 46.59% | 46.58% | 46.65% | 94.81% | 99.44% | 99.73% | 99.8% |
| Promoters | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.41% | 53.34% | 5.19% | 0.0% | 0.0% | 0.0% |
| FII | 0.0% | 0.0% | 0.02% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.56% | 0.28% | 0.2% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.01% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Take Limited (this stock) | 229 | 38.9 | 7.38 | 16.5% |
| Nectar Lifesciences Ltd. | 211 | — | 0.36 | -31.3% |
| Bilcare Ltd. | 257 | 12.9 | 1.3 | 1.39% |
| Brooks Lab Limited | 180 | 13.7 | 1.47 | 22.0% |
| Natural Capsules Limited | 176 | — | 1.01 | -9.45% |
| Bal Pharma Ltd. | 175 | 24.4 | 2.13 | 7.87% |
| Parnax Lab Ltd. | 149 | 14.8 | 1.56 | 14.4% |
Which Mutual Funds Hold Take Limited?
Frequently Asked Questions about Take Limited
Take Limited (TAKE) closed at ₹15.51 on NSE on 25 September 2026, up 0.11 (0.71%) from the previous close.
Take Limited trades on the NSE (National Stock Exchange of India) under the symbol TAKE.
Take Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 38.9.
Take Limited has a dividend yield of 0.0%.
Take Limited's 52-week high is ₹50.1 and its 52-week low is ₹10.5.
Take Limited has a market capitalisation of ₹229 crore.
Take Limited has a TopFund Quality Score of 39/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Take Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.